Valeant Pharmaceuticals International - Comparative Business Analysis Snapshot

Business Description
Valeant Pharmaceuticals International. The Group's principal activity is to develop, manufacture and market prescription and non-prescription pharmaceutical products principally in the areas of neurology and dermatology. The Company's growth strategy is to acquire, develop and commercialize new products through strategic partnerships, and build on the company's market in neurology and dermatology. The Group's markets focus primarily in the United States, Canada, Mexico, Brazil and Australia. Headquartered in Orange County, California, Valeant has approximately 2,600 employees worldwide.

Competitor Analysis
This analysis compares Valeant Pharmaceuticals International with three other companies in closely related industry sectors.

The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports